# STREAM Trial - Subclinical Atherosclerosis

> **NCT05482399** · NA · RECRUITING · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 500 (estimated)

## Conditions studied

- Statin Treatment for Primary Prevention

## Interventions

- **OTHER:** Statin discontinuation

## Key facts

- **NCT ID:** NCT05482399
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-21
- **Primary completion:** 2026-11
- **Final completion:** 2026-11
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05482399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05482399, "STREAM Trial - Subclinical Atherosclerosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05482399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*